Corporate Documents

California Compliance Program Overview

Authorized Distributors of Record

Price Transparency

Vermont Pricing Disclosure Short Form – Aptiom^® (eslicarbazepine acetate)

Vermont Pricing Disclosure Long Form – Aptiom^® (eslicarbazepine acetate)

Vermont Pricing Disclosure Short Form – Gemtesa^® (vibegron)

Vermont Pricing Disclosure Long Form – Gemtesa^® (vibegron)

Vermont Pricing Disclosure – Latuda^® (lurasidone HCl tablets)

Vermont Pricing Disclosure Short Form – Myfembree^® (relugolix, estradiol, and norethindrone acetate)

Vermont Pricing Disclosure Long Form – Myfembree^® (relugolix, estradiol, and norethindrone acetate)

Vermont Pricing Disclosure Short Form – Orgovyx^® (relugolix)

Vermont Pricing Disclosure Long Form – Orgovyx^® (relugolix)

Colorado WAC Disclosure Form – Aptiom^® (eslicarbazepine acetate)

Colorado WAC Disclosure Form – Gemtesa^® (vibegron)

Colorado WAC Disclosure Form – Myfembree^® (relugolix, estradiol, and norethindrone acetate)

Colorado WAC Disclosure Form – Orgovyx^® (relugolix)

Colorado WAC Disclosure Form – Rethymic^® (allogeneic processed thymus tissue–agdc)

Connecticut Pricing Disclosure – Aptiom^® (eslicarbazepine acetate)

Connecticut Pricing Disclosure – Gemtesa^® (vibegron)

Connecticut Pricing Disclosure – Myfembree^® (relugolix, estradiol, and norethindrone acetate)

Connecticut Pricing Disclosure – Orgovyx^® (relugolix)

Connecticut Pricing Disclosure – Rethymic^® (allogeneic processed thymus tissue–agdc)